Literature DB >> 22373097

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Ingo Jordan1, Volker Sandig1.   

Abstract

Entities:  

Year:  2011        PMID： 22373097      PMCID： PMC3284961          DOI： 10.1186/1753-6561-5-S8-O1

Source DB:  PubMed          Journal:  BMC Proc        ISSN： 1753-6561


× No keyword cloud information.
  4 in total

1.  An avian cell line designed for production of highly attenuated viruses.

Authors:  Ingo Jordan; Ad Vos; Stefanie Beilfuss; Andreas Neubert; Sabine Breul; Volker Sandig
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

2.  A chemically defined production process for highly attenuated poxviruses.

Authors:  Ingo Jordan; Stefan Northoff; Michael Thiele; Stefan Hartmann; Deborah Horn; Kristin Höwing; Holger Bernhardt; Stefanie Oehmke; Henning von Horsten; Dierk Rebeski; Lars Hinrichsen; Vladimir Zelnik; Wiebke Mueller; Volker Sandig
Journal:  Biologicals       Date:  2011-01-15       Impact factor: 1.856

3.  An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.

Authors:  Silvia Perri; Catherine E Greer; Kent Thudium; Barbara Doe; Harold Legg; Hong Liu; Raul E Romero; Zequn Tang; Qian Bin; Thomas W Dubensky; Michael Vajdy; Gillis R Otten; John M Polo
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.

Authors:  V Lohr; A Rath; Y Genzel; I Jordan; V Sandig; U Reichl
Journal:  Vaccine       Date:  2009-06-14       Impact factor: 3.641
  4 in total
  1 in total

1.  High-cell-density cultivations to increase MVA virus production.

Authors:  Daniel Vázquez-Ramírez; Yvonne Genzel; Ingo Jordan; Volker Sandig; Udo Reichl
Journal:  Vaccine       Date:  2018-02-09       Impact factor: 3.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.